Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-12-06
2005-12-06
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S068100, C435S252000, C210S652000, C426S043000
Reexamination Certificate
active
06972282
ABSTRACT:
The invention relates to a process for preparing a product containing antihypertensive peptides by fermenting a casein-containing starting material with lactic acid bacteria. The invention also relates to the obtained product and its use as a functional product as such or as an ingredient or additive of edible substances.
REFERENCES:
patent: 4409247 (1983-10-01), Baret et al.
patent: 5449661 (1995-09-01), Nakamura et al.
patent: 6514941 (2003-02-01), Tolton et al.
patent: 0 737 690 (1996-10-01), None
patent: 0 821 968 (1999-07-01), None
patent: 104783 (2000-04-01), None
patent: 2 294 191 (1996-04-01), None
patent: 11-98978 (1999-04-01), None
patent: 99/16862 (1999-04-01), None
Jeantet et al. “Semicontinuous production of lactic acid in a bioreactor coupled with anofiltration membranes” Enz. Microb. Technol. (1996) 19: 614-619.
Webster's II New Riverside Dictionary (1994) (Houghton-Mifflin: Boston MA) p. 417.
WPI, Derwent, accession No. 1986-110323, Calpis Shokuhin Kogyo KK: “Drug for prophylaxis of hypotension—contains high mol. substance obtd. by removing cell and casein from fermented milk”, & JP 61053216, 19860317.
PAJ/JPO, “Peptide, Angiotensinase Inhibiting Composition and Their Production”, Otsuka Shokuhin KK, &JP 9188694, 19970722'.
Anne Pihlanto-Leppala et al; “Angiotensin I Converting Enzyme Inhibitory Peptides Derived from Bovine Milk Proteins”, Int. Dairy Journal, vol. 8, 1998, p. 331.
Jeantet, R. et al; Caplus Copyright 2001 ACS, accession No. 1996:467944, “***Nanofiltration*** benefit for production of spray-dried demineralized whey powder”, 1996, vol. 76 (3), pp. 283-301.
Hutosn, T.; “*** Nanofiltration*** and ion exchange for the demineralization of whey”,Int. Dairy Fed, 1998, vol. 9804, pp. 88-92, ISSN: 1025-8515.
Bouhallab et al; accession No. 1995:899699 Caplus, “Continuous hydrolysis of caseinomacropeptide in a membrance reactor: Kinetic study and gram-scale production of antithrombotic ***peptides***”, 1995, vol. 75(3), pp. 251-258.
Yamamoto Naoyuki et al; “Antihypertensive Effect of the Peptides Derived From Casein by an Extracellular Proteinase from Lactobacillus Helvetlcus CP790”, J Dairy Sci., vol. 77, 1994, pp. 917-922.
WPI, Derwent, accession No. 1994-268691, Calpis Shokuhin Kogyo KK: “Prepn. of peptide whichinhibits angiotensin conversion enzyme-by lactic acid bacterium culture of material with specified tri: peptide sequence”; & JP A 6197786, 19940719.
Yasunori, Nakamura et al.; “Purification and Characterization of Angiotensin I-Converting Enzyme Inhibitors from Sour Milk”, J. Dairy Sci., 1995, vol. 78, pp. 777-783.
Yamamoto et al J. Biochem 114, 740-745 (1993) Purification and Specificity of a Cell-Wall-Associated Proteinase fromLactobacillus helveticusCP790.
Holmquist et al Analytical Biochemistry 95, 540-548 (1979) A continuous Spectrophotometric Assay for Angiotensin Converting Enzyme.
Mäyrä-Mäkinen Annika
Sahlstein Janne
Suomalainen Tarja
Tossavainen Olli
Hanley Susan
Nixon & Vanderhye P.C.
Valio Ltd.
Witz Jean C.
LandOfFree
Process for producing a product containing antihypertensive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing a product containing antihypertensive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing a product containing antihypertensive... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3519621